Emergent Biosolutions Stock Looks Attractive Despite A 3x Move

Despite a stellar 2.6x rise since the March 23 lows of this year, at the current price of around $130 per share we believe Emergent Biosolutions, best known for its vaccines, antibody therapeutics, and biodefense related medical devices, looks attractive and it has more room for growth…

About the Author

has written 23527 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com